Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Common Equity (2023 - 2025)

Historic Common Equity for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $7.7 million.

  • Bioharvest Sciences' Common Equity rose 8688.09% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 8688.09%. This contributed to the annual value of $1.3 million for FY2024, which is 10895.44% up from last year.
  • According to the latest figures from Q3 2025, Bioharvest Sciences' Common Equity is $7.7 million, which was up 8688.09% from -$4.2 million recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Common Equity peaked at $7.7 million during Q3 2025, and registered a low of -$14.9 million during Q4 2023.
  • For the 3-year period, Bioharvest Sciences' Common Equity averaged around $138333.3, with its median value being $2.7 million (2024).
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 10895.44% in 2024, then plummeted by 16301.1% in 2025.
  • Bioharvest Sciences' Common Equity (Quarter) stood at -$14.9 million in 2023, then surged by 108.95% to $1.3 million in 2024, then soared by 481.58% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q3 2025, -$4.2 million for Q2 2025, and $1.3 million during Q4 2024.